Ishinkai Oda Clinic

Presidnet and director

Harunori Oda

Harunori Oda
Globalizing medical practice through immunotherapy-based preventive medicine

Ishinkai Oda Clinic focuses on the early detection and prevention of cancer with the introduction of cutting-edge medicine, NKM cellular immunotherapy and stem cell therapy. I have many patients from overseas, being licensed to practice medicine in China and South Korea as well as in Japan and being able to speak Japanese, Chinese, Korean and English. Our clinic owns cell processing facilities in Japan and China. Emphasizing fundamental research on preventive medicine from a global perspective, I hope our research will be used effectively in society.

Year of Birth
1954
Birthplace
Jilin, China
Name
Ishinkai Oda Clinic
Headquarters
Tokyo
Founded
1995
Type of business
Regenerative medicine
url
https://www.ishinkai-mc.net
My father was a physician and my mother was a pharmacist. Naturally, I became a medical doctor. I was interested in preventive medicine before entering university. In China, there is the system in which young people experience agriculture and more for three years while staying in a rural village and living with community members before they go to university. The program tests whether you are qualified to study at university to become a medical doctor. It only permits those who receive recommendations from community members at the end of the program to go to university. It is a very big hurdle—only one out of dozens can enter university. Having a strong sense of purpose about becoming a physician, I took the wellness of community members seriously. I started to think that I should start with the prevention of diseases before treating them after finding that many people have difficulty recovering from chronic diseases. I started to make a decoction of herbs and distribute it to community members under the supervision of the person in charge of the local medical practice. It was my first experience learning about preventive medicine based on Chinese herbal medicine. The idea is to prevent diseases by having decocted seasonal herbs and increasing immunity. Local people said that they became more resistant to disease and even if they became infected, they recovered more quickly. The experience made me recognize the importance of preventive medicine. It was my first encounter with preventive medicine and the starting point of my career as a passionate physician. Three years later, I entered medical school, having received recommendations from community members. Then, I started to study medicine, hoping to work in Japan, the country of my roots.
However, there were many legal obstacles for international education in medicine. It is difficult to become qualified as a medical professional in Japan for those who have only graduated from medical school in China. I went to South Korea to study more and graduated from another medical school in China. I finally became a medical doctor in Japan, having the necessary research and accumulated experience in multiple countries after years. Sometimes I was frustrated by such a troublesome qualification process, however, those experiences helped me acquire a global perspective and perception of healthcare. Medicine-related laws and people’s consciousness are completely different in Japan and other countries. For instance, the Japanese medical system is based on national medical insurance. Therefore, patients seldom want therapies beyond the scope of the insurance. However, in some countries, patients are more inclined to go for the best choice from a variety of combinations of private practice and the therapies covered by medical insurance. To grow as a medical doctor, I should not only rely on health insurance treatment. I thought I should do research on state-of-the-art healthcare while concentrating on private practice. I decided to open and manage a clinic as the place to carry out my ideal medical care and research. When I first opened my clinic based on immunotherapy, 99% of the patients had cancer. The high effectiveness and safety of immunotherapy was proven while I treated cancer patients and conducted further research on immunotherapy from the perspective of preventive medicine. Consequently, I acknowledge the importance of the early commencement of treatment.
I have found a new goal while seeing many patients—the diversification of treatment. The human body is based on a minute and delicate balance. Therefore, symptoms and effective therapies vary by patient. A single therapy is insufficient to treat a patient in most cases. The future challenge for healthcare is to combine many different methods and customize them for each patient. For this, it would be difficult to obtain results by only staying in your home country to do research. Now, the medical practice is becoming internationalized. Hopefully, for the further development of healthcare in Asia and the world, Japan will have more open research laboratories so that researchers and information can be exchanged internationally. Today, it is difficult to have research facilities in Japan. Therefore, we are advancing research projects on preventive medicine at a laboratory in a special medical zone in China. This laboratory satisfies the criteria required in Japan and has obtained permission from the Ministry of Health, Labour and Welfare. We would like to serve as a mediator between Japan and other countries so that Japan can keep up with the evolution of the healthcare industry by having good research organizations and transmitting results. The healthy life expectancy of Japanese patients will be extended, quality of life will improve and patients’ families will feel reassured if diseases can be detected early, and anti-aging treatments can be provided as well as the prevention of cancer. It would be extremely valuable if diseases could be prevented, making many people happy. I have a project in mind to establish a system for involving world-class physicians and surgeons to give instructions and/or see patients remotely, and local medical professionals to treat patients face-to-face. If it is achieved, many more patients will survive. We will continue to make efforts in daily research on cutting-edge treatment to materialize the practical use of our research results as soon as possible.
Harunori Oda
Harunori Oda

*Information accurate as of time of publication.

Ishinkai Oda Clinic

Presidnet and director
Harunori Oda